Concepedia

Leutz Buon

LB

15

Publications

670

Citations

12

H-Index

2009

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

VA Boston Healthcare System

Pt. Jawahar Lal Nehru Memorial Medical College

Massachusetts General Hospital

Leutz Buon is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

2009–2023

15

Publications

15

Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia

Shruti Bhatt, Marissa S. Pioso, Elyse A. Olesinski et al. · Cancer Cell · 2020 · 165 citations · Full text

, , +11

Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide

Benedetta Rambaldi, Haesook T. Kim, Carol Reynolds et al. · Blood Advances · 2021 · 99 citations · Full text

, , +16

Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

Melissa Ooi, Patrick Hayden, Vassiliki Kotoula et al. · Clinical Cancer Research · 2009 · 70 citations · Full text

Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome

Jagannath Pal, Robert C. Bertheau, Leutz Buon et al. · Oncogene · 2011 · 63 citations

, , +9

Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma

Douglas W. McMillin, Hannah M. Jacobs, Jake Delmore et al. · Molecular Cancer Therapeutics · 2012 · 55 citations · Full text

, , +13

Rows per page

1–5 of 15